Production logistics and radionuclidic purity aspects of 153Sm for radionuclide therapy

Simple item page
dc.contributor.authorRamamoorthy, N.
dc.contributor.authorSaraswathy, P.
dc.contributor.authorDas, M. K.
dc.contributor.authorMehra, K. S.
dc.contributor.authorAnanthakrishnan, M.
dc.date.accessioned2019-10-30T09:52:57Z
dc.date.available2019-10-30T09:52:57Z
dc.date.issued2002
dc.description.divisionRPhDen
dc.format.extent4898 bytes
dc.format.mimetypetext/html
dc.identifier.sourceNuclear Medicine Communications, 2002. Vol. 23: pp. 83-89en
dc.identifier.urihttp://hdl.handle.net/123456789/19812
dc.language.isoenen
dc.subject153Smen
dc.subject186Reen
dc.subjectnatural Sm2O3 targeten
dc.subjectenriched 152Sm targeten
dc.subjectradionuclidic impurities 154Eu and 155Euen
dc.subjectradionuclide therapyen
dc.titleProduction logistics and radionuclidic purity aspects of 153Sm for radionuclide therapyen
dc.typeArticleen

Click here to download

Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
0416.htm
Size:
4.78 KB
Format:
Hypertext Markup Language
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.81 KB
Format:
Item-specific license agreed upon to submission
Description:
Download

Collections

2002